1,939 Shares in HealthEquity, Inc. $HQY Bought by Abel Hall LLC

Abel Hall LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQY) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,939 shares of the company’s stock, valued at approximately $203,000.

A number of other large investors have also recently bought and sold shares of HQY. Invesco Ltd. boosted its holdings in HealthEquity by 50.6% in the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock worth $216,171,000 after purchasing an additional 821,425 shares in the last quarter. Nuveen LLC acquired a new position in HealthEquity in the 1st quarter valued at $53,076,000. Price T Rowe Associates Inc. MD grew its stake in HealthEquity by 995.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company’s stock valued at $56,500,000 after buying an additional 580,988 shares during the last quarter. Westfield Capital Management Co. LP acquired a new position in HealthEquity in the 1st quarter valued at $49,787,000. Finally, Ameriprise Financial Inc. grew its stake in HealthEquity by 148.1% in the 1st quarter. Ameriprise Financial Inc. now owns 669,939 shares of the company’s stock valued at $59,203,000 after buying an additional 399,897 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of research analyst reports. Royal Bank Of Canada raised their target price on shares of HealthEquity from $109.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, September 3rd. Barrington Research reiterated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research note on Friday, August 29th. JPMorgan Chase & Co. raised their target price on shares of HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. Jefferies Financial Group raised their price target on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $121.31.

Insider Transactions at HealthEquity

In other news, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president directly owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. This trade represents a 7.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of the firm’s stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

HealthEquity Stock Performance

NASDAQ HQY opened at $92.09 on Thursday. The company’s fifty day moving average is $91.71 and its two-hundred day moving average is $93.82. The firm has a market capitalization of $7.93 billion, a price-to-earnings ratio of 55.81, a P/E/G ratio of 1.27 and a beta of 0.47. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.